Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer

One of the major challenges in the treatment of cancer are differential responses of patients to existing standard of care anti-cancer drugs. These differential responses may, in part, be due to a diverse range of genomic, epigenomic, proteomic, and metabolic alterations among individuals suffering...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Tanya, Neal, Adam S., Moatamed, Neda A., Memarzadeh, Sanaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794771/
https://www.ncbi.nlm.nih.gov/pubmed/33396714
http://dx.doi.org/10.3390/ijms22010305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794771/
https://www.ncbi.nlm.nih.gov/pubmed/33396714
http://dx.doi.org/10.3390/ijms22010305

Ejemplares similares